Share on LinkedInShare on LinkedIn

ARTICLE · 06 JULY 2023

USPTO To Launch Cancer Moonshot Expedited Examination Pilot Program

In other words, accepted applications will be advanced out of turn for examination.

United StatesIntellectual Property

As per a notice[1] ("the notice") dated December 9, 2022, the United States Patent and Trademark Office ("USPTO") has announced that beginning February 1, 2023, an expedited examination program will be launched to replace the Cancer Immunotherapy Pilot Program.[2] Under the new Cancer Moonshot Expedited Pilot Program ("the new pilot program"), accepted applications pertaining to broadened scope of qualifying technologies will be accorded special status until a first Office action.[3] In other words, accepted applications will be advanced out of turn for examination. The pilot program will run until the earlier of either January 31, 2025, or the date that a total of 1000 grantable petitions have been accepted under the pilot program.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from